Align Technology | ALGN - Interest Expense On Debt


Align Technology reported $16.04M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
3M USD 214M 18M Mar/2026
Align Technology USD 16.04M 14.04M Dec/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Cardinal Health USD 101M 13M Mar/2026
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
CVS Health USD 774M 13M Mar/2026
Danaher USD 63M 8M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Dexcom USD 4.2M 500K Dec/2025
Henry Schein USD 39M 0 Mar/2026
Idexx Laboratories USD 7.74M 2.34M Mar/2026
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.46M 1.21M Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Masimo USD 6.1M 1.4M Mar/2026
McKesson USD 63M 11M Dec/2025
Mettler Toledo International USD 17.39M 307K Dec/2025
Revvity USD 24.72M 1.2M Mar/2026
Solventum Corp USD 14.1B 14.05B Mar/2026
Stryker USD 46.29B 45.68B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
Veeva Systems USD 65.1M 8.4M Mar/2025
Waters USD 42M 33.38M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026
Zoetis USD 62M 5M Mar/2026